Clinical Trials Directory

Trials / Unknown

UnknownNCT06189144

Testing an Intervention in Irritative Contact Dermatitis

Testing the Effectiveness of an Intervention in Irritative Contact Dermatitis:Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
University of Split, School of Medicine · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, itchiness and lichenification. Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells, which trigger inflammation by activation of the innate immune system.

Detailed description

An eczematous reaction is an inflammatory intolerance response of the skin. In acute phase the reaction is characterized by erythema and blistering while in the chronic phase it presents as dryness, itchiness and lichenification. Irritative contact dermatitis describes these patterns of reaction in response to toxicity of chemicals on the skin cells, which trigger inflammation by activation of the innate immune system. Therefore, the aim of this study was to see if omega cream, as proposed by its mechanism of action, could improve SLS induced contact dermatitis.

Conditions

Interventions

TypeNameDescription
OTHEREmollient cream treatmentRilastil Difesa Sterile cream
OTHERno treatmentno treatment

Timeline

Start date
2023-06-01
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2024-01-03
Last updated
2024-01-03

Locations

1 site across 1 country: Croatia

Source: ClinicalTrials.gov record NCT06189144. Inclusion in this directory is not an endorsement.